insights_auto
Why is VRAX down 5,69%?
Dive Deeperchevron_right
VRAX:NASDAQ
Virax Biolabs Group Ltd
1,99 USD
arrow_downward
-5,69%(-0,12) 1D
1,78 USD
arrow_downward
-10,55% (-0,21)todayPre-market
Closed: 8-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRAX...
Open
2,13 USD
High
2,13 USD
Low
1,93 USD
Mkt. cap
2,63 млн
Avg. vol.
149,66 миң
Volume
0,00
52-wk high
21,75 USD
52-wk low
1,83 USD
EPS
-12,64 USD
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
Open
2,13 USD
High
2,13 USD
Low
1,93 USD
Mkt. cap
2,63 млн
Avg. vol.
149,66 миң
Volume
0,00
52-wk high
21,75 USD
52-wk low
1,83 USD
EPS
-12,64 USD
Beta
1,40
Shares outstanding
1,34 млн
No. of employees
26
News stories
From web sources and news partners
Endpoints News
·
28 мүнөт мурун
TRexBio prices $117M IPO for Tregs as Retension lands $45M Nasdaq debut for hypertension
Yahoo Finance UK
·
1 саат мурун
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
dailyadvance.com
·
20 мүнөт мурун
World shares are mostly higher and crude prices fall after an unsettled day on Wall St
Seeking Alpha
·
1 саат мурун
S&P 500 Sector Outlook: Favor XLC And XLK, Underweight XLP With Uneven Earnings Leadership
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
HeadquartersЛондон, Ингленд, Улуу Британия
SectorHealth care provider
Websiteviraxbiolabs.com